Predictive Value of 24-Hour Bilirubin in Developing Hyperbilirubinemia among Term Infants in a Multi-Center Study in the Philippines
OHRPA
Ongoing Projects
Assessment of Diagnostic Algorithms and Tools for Multidrug Resistant and Drug Sensitive Tuberculosis in the Philippines Part II (TB-FIT 2)
De La Salle Medical and Health Sciences Institute (DLSMHSI)
OHRPA
Long Term outcomes of Diagnosed Tuberculosis Cases in the Philippines
National Institutes of Health - UP Manila
OHRPA
Community Approach to Control and Halt Drug-Resistant TB (COACH DRTB)
De La Salle Medical and Health Sciences Institute (DLSMHSI)
OHRPA
Prospective Urban and Rural Epidemiologic (PURE) Study
Philippine General Hospital
OHRPA
The International Polycap Study 3 (TIPS3)
Philippine General Hospital
OHRPA
The Philippine COPD Profile and Survival Study (CPASS): A Multicenter, Prospective Cohort, Observational Study
Philippine College of Chest Physicians
OHRPA
G.T.A.R.A.: Grip/Grasp Training with Active Range of Motion Activities using Guitar
UP Diliman
Re-emerging and Emerging Diseases (RED)
Aptamer-Based Multiplex Assay for the Early Detection of Leptospirosis
UP Diliman
Diagnostics
Enteric Solutions: Development of a Vertical Flow Microarray (VFM) for the Detection of Enteric Viruses
UP Diliman
Diagnostics
Development of Novel Detection Tools for the Integrated Surveillance and Monitoring of Helminthic Neglected Tropical Diseases (NTDs) of Mutual Public Health Importance in the Philippines and China
UP Diliman
Diagnostics
Clinical Proteomics for Cancer Initiative: A Proteomics-Based Discovery of Non-Small Cell Lung Cancer Biomarkers and Drug Targets in the Philippines: Project 3: Proteomic analysis of aberrant protein expression in Non-Small Cell Lung Cancer (NSCLC)
UP Diliman
Omics for Health
Clinical Proteomics for Cancer Initiative: A Proteomics-Based Discovery of Non-Small Cell Lung Cancer Biomarkers and Drug Targets in the Philippines: Project 2: Sample Processing for Proteomic Analysis and Functional Characterization and Early Clinical Confirmation of Biomarker Application
UP Diliman
Omics for Health
Installation and Operation of the Philippine Genome Center -Protein Proteomics, and Metabolomics Facility (PPMF)
UP Diliman
Omics for Health
Filipino Genomes Region for to Help Resolve Child Sexual Abuse Cases
UP Diliman
Omics for Health
Filipino Genomes: History, Evolution, Origins and Applications
UP Diliman
Omics for Health
Filipino Forensic Genomics (Phase I)
UP Diliman
Omics for Health
Development of Breast Cancer Mammosphere Assay for Chemotherapy Screening
UP Diliman
Omics for Health
Development of HIV Disease Models and in vitro Investigation of HIV-related Neurocognitive and Metabolic Complications
UP Diliman
Omics for Health
Discovery and Development of Health Products: Disease-Specific Bioactive Hits from Terrestrial Organisms: Confirmatory and Orthogonal Assays to Eliminate Artefactual Drug Bioactivities (Phase 3): Continuing Needs of the Tuklas Lunas Program
UP Diliman
Tuklas Lunas
Philippine Biorepository Network: Development of Biobanking Facility for Plant Extracts/Compounds for Drug Discovery
UP Diliman
Tuklas Lunas
DDHP: Marine Component Phase 2: Project 2. Anti-Infective and Anti-Cancer Drug Candidates from Marine Microorganisms and Sponges: Discovery and Development
UP Diliman
Tuklas Lunas
DDHP: Marine Component Phase 2: Project 1. Anti-Pain and Anti-Neurodegeneration Drug Candidates: Discovery and Development
UP Diliman
Tuklas Lunas
Bridging Efficacy and Safey: IND-enabling Suite of ADMETox Assays: Project 3. HPLC and Mass Spectral Studies to Support Various ADMET assays
UP Diliman
Tuklas Lunas
Bridging Efficacy and Safey: IND-enabling Suite of ADMETox Assays: Project 2. Cell-based ADMET assays
UP Diliman
Tuklas Lunas
Bridging Efficacy and Safey: IND-enabling Suite of ADMETox Assays Project 1. Optimization of Physico-Chemical Drug Properties
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II) Project 6. Computer-Aided Drug Design of Natural Products-Based, and Synthetic Antidiabetic, Antifungal, and Anticancer Lead Compounds and Derivatives
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II): Project 3. Synthesis of Deguelin, Rotenone, and Small Molecule Derivatives as Anticancer Agents
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II): Project 2. Molecular Docking and ADME-Tox–guided Synthesis of Azole-Based Anti-Infective Agents
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II): Project 1. Lead Optimization, In Silico Prediction, Molecular Docking and Determination of ADMETox Properties of Small Molecules as Antidiabetic Drugs
UP Diliman
Tuklas Lunas
Discovery and Development of Health Products (DDHP): Disease-Specific Bioactive Hits from Terrestrial Organisms Project 11. De-replication with LC-MS Based Metabolomics
UP Diliman
Tuklas Lunas
Technical Battle Against COVID: Project 2. Rational Design and Structural Modifications of ACE2 Inhibitors from Terrestrial Plants
UP Diliman
Covid-19
Technical Battle Against COVID: Project 1. Design and Synthesis of SARS-COV2, ACE2, SARS- COV2:ACE2 Destabilizing Compounds
UP Diliman
Covid-19
CRISPR-based Diagnostics (CRISPR-Dx) for the detection of SARS-CoV-2 and TB
UP Diliman
Covid-19
Compounds Active Against Cancer Lines (HCT116, MCF7, A549) from Priority Extracts – Phase II
UP Diliman
Tuklas Lunas
Discovery and Development of Health Products [DDHP]: Formulation, Standardization, and Metabolic Profiling of Disease-Specific Top-Tier Plants for Pre-Clinical and Clinical Development Project 3. Standardized Dosage Forms of Biologically Active Extracts Suitable for Use in Pre-clinical and Clinical Research: Top Tier Herbs for Cancer
UP Diliman
Tuklas Lunas
Structure Identification of Anti-inflammatory and Anti-Pain Agents from Priority Extracts (Phase 4)
UP Diliman
Tuklas Lunas
Anti-inflammatory and Anti-diabetic compounds from top-tier bioactive extracts
UP Diliman
Tuklas Lunas
Establishing an Antibody Neutralization Assay for Characterization and Immunosurveillance of Emerging SARS-COV-2 Variants of Concern
UP Diliman
Covid-19
